Concepedia

Mazin Abdelghany

MA

6

Publications

1.6K

Citations

6

H-Index

2020

Active since

Affiliations

University of California, San Francisco(Current)

Chan Zuckerberg Initiative (United States)

Harvard University

University of Colorado Denver

Massachusetts General Hospital

Mazin Abdelghany is an author at University of California, San Francisco specializing in medicine, immunology, and multiomics.

ORCID

Top concepts

Publications per year

2020–2023

6

Publications

6

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Robert Gottlieb, Carlos Vaca, Roger Paredes et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults

Katrina Kalantar, Lucile Neyton, Mazin Abdelghany et al. · Nature Microbiology · 2022 · 132 citations · Full text

, , +19

Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections

Paula Hayakawa Serpa, Xianding Deng, Mazin Abdelghany et al. · Genome Medicine · 2022 · 105 citations · Full text

Obesity Is Associated With Pulmonary Hypertension and Modifies Outcomes

R Frank, Jeff Min, Mazin Abdelghany et al. · Journal of the American Heart Association · 2020 · 85 citations · Full text

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

Samuel M. Brown, Christina E. Barkauskas, Birgit Grund et al. · The Lancet Respiratory Medicine · 2023 · 19 citations · Full text

, , +6

Rows per page

1–5 of 6